These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15541390

  • 1. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
    Gokturk C, Nordquist J, Sugimoto H, Forsberg-Nilsson K, Nilsson J, Oreland L.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):1013-20. PubMed ID: 15541390
    [Abstract] [Full Text] [Related]

  • 2. Origins of serum semicarbazide-sensitive amine oxidase.
    Stolen CM, Yegutkin GG, Kurkijärvi R, Bono P, Alitalo K, Jalkanen S.
    Circ Res; 2004 Jul 09; 95(1):50-7. PubMed ID: 15178639
    [Abstract] [Full Text] [Related]

  • 3. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S.
    FASEB J; 2004 Apr 09; 18(6):702-4. PubMed ID: 14977883
    [Abstract] [Full Text] [Related]

  • 4. Semicarbazide-sensitive amine oxidase (SSAO) gene expression in alloxan-induced diabetes in mice.
    Nordquist JE, Göktürk C, Oreland L.
    Mol Med; 2002 Dec 09; 8(12):824-9. PubMed ID: 12606817
    [Abstract] [Full Text] [Related]

  • 5. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V, Bour S, Boucher J, Prévot D, Valet P, Ordener C, Parini A, Carpéné C.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):139-46. PubMed ID: 16202994
    [Abstract] [Full Text] [Related]

  • 6. Macrovascular changes in mice overexpressing human semicarbazide-sensitive amine oxidase in smooth muscle cells.
    Gokturk C, Sugimoto H, Blomgren B, Roomans GM, Forsberg-Nilsson K, Oreland L, Sjoquist M.
    Am J Hypertens; 2007 Jul 17; 20(7):743-50. PubMed ID: 17586408
    [Abstract] [Full Text] [Related]

  • 7. SSAO/VAP-1 protein expression during mouse embryonic development.
    Valente T, Solé M, Unzeta M.
    Dev Dyn; 2008 Sep 17; 237(9):2585-93. PubMed ID: 18729210
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas.
    Göktürk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Söderberg C, Israelson M, Garpenstrand H, Sjöquist M, Oreland L, Forsberg-Nilsson K.
    Am J Pathol; 2003 Nov 17; 163(5):1921-8. PubMed ID: 14578191
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H, Sugimoto H, Obata T, Satoh N, Ueda S.
    Neurotoxicology; 2004 Jan 17; 25(1-2):325-35. PubMed ID: 14697907
    [Abstract] [Full Text] [Related]

  • 10. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats.
    Hayes BE, Clarke DE.
    Res Commun Chem Pathol Pharmacol; 1990 Jul 17; 69(1):71-83. PubMed ID: 2218072
    [Abstract] [Full Text] [Related]

  • 11. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.
    Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A.
    Neurochem Int; 2006 Jun 17; 48(8):746-52. PubMed ID: 16524643
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM, Wang EY, Miller A, Podar EM, Scheyhing K, Huang L, Kessler C, Gao H, Ton-Nu HT, Macdonald MT, Jones DS, Linnik MD.
    J Pharmacol Exp Ther; 2008 Feb 17; 324(2):867-75. PubMed ID: 17993604
    [Abstract] [Full Text] [Related]

  • 16. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
    Yu PH, Lu LX, Fan H, Kazachkov M, Jiang ZJ, Jalkanen S, Stolen C.
    Am J Pathol; 2006 Mar 17; 168(3):718-26. PubMed ID: 16507887
    [Abstract] [Full Text] [Related]

  • 17. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.
    Grès S, Bour S, Valet P, Carpéné C.
    J Physiol Biochem; 2012 Dec 17; 68(4):651-62. PubMed ID: 22547093
    [Abstract] [Full Text] [Related]

  • 18. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport.
    Mercier N, Moldes M, El Hadri K, Fève B.
    J Pharmacol Exp Ther; 2003 Mar 17; 304(3):1197-208. PubMed ID: 12604697
    [Abstract] [Full Text] [Related]

  • 19. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
    Yraola F, García-Vicente S, Fernandez-Recio J, Albericio F, Zorzano A, Marti L, Royo M.
    J Med Chem; 2006 Oct 19; 49(21):6197-208. PubMed ID: 17034126
    [Abstract] [Full Text] [Related]

  • 20. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
    Yu PH, Wang M, Fan H, Deng Y, Gubisne-Haberle D.
    Am J Physiol Endocrinol Metab; 2004 Apr 19; 286(4):E634-41. PubMed ID: 14656718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.